Efficacy and safety of 7 versus 14 days of antibiotic treatment for Pseudomonas aeruginosa bacteraemia: a multicentre, randomized clinical trial (SHORTEN-2) with a DOOR/RADAR analysis
Promotores: Jose Miguel Cisneros y Jose Molina. Hospital Virgen del Rocío. Sevilla
Randomised, open-label, non-inferiority clinical trial on the efficacy and safety of a 7-day vs 14-day course of antibiotic treatment for uncomplicated enterococcal bacteraemia: the INTENSE trial protocol
Maldonado N, Rosso-Fernández CM, Portillo-Calderón I, Borreguero Borreguero I, Tristán-Clavijo E, Palacios-Baena ZR, Salamanca E, Fernández-Cuenca F, De-Cueto M, Stolz-Larrieu E, Rodriguez-Baño J, López-Cortés LE. BMJ Open. 2023 Sep 6;13(9):e075699. doi: 10.1136/bmjopen-2023-075699. PMID: 37673453
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
Federico Becerra-Aparicio 1, Silvia Gómez-Zorrilla 2 3, Marta Hernández-García 1 3, Desiré Gijón 1, Ana Siverio 2 4, Dàmaris Berbel 5, Carlos Sánchez-Carrillo 6, Emilia Cercenado 6 7, Alba Rivera 8, Ana de Malet 9, Mariona Xercavins 10, Enrique Ruiz de Gopegui 3 11, Luis Canoura-Fernández 12, José Antonio Martínez 13, Cristina Seral 14, José Luis Del Pozo 15, Manuel Cotarelo 16, Jazmín Díaz-Regañón 16, Rafael Cantón 1 3, Antonio Oliver 3 11, Juan Pablo Horcajada 2 3, Patricia Ruiz-Garbajosa 1 3. J Antimicrob Chemother. 2023 Sep 5;78(9):2291-2296. doi: 10.1093/jac/dkad234.
Randomized Clinical Trial of the Need for Antibiotic Treatment for Low-Risk Catheter-Related Bloodstream Infection Caused by Coagulase-Negative Staphylococci
Badia-Cebada L, Carmezim J, Pérez-Rodríguez MT, Bereciartua E, López LE, Montenegro MR, Pomar V, Andrés M, Petkova E, Sopena N, Lora-Tamayo J, Monsálvez V, Ramirez-Hidalgo MF, Gómez-Zorrilla S, Boix L, Meije Y, Jiménez E, Gasch O. Antibiotics (Basel). 2023 May 1;12(5):839. doi: 10.3390/antibiotics12050839. PMID: 37237744
Pseudomonas aeruginosa community-onset bloodstream infections: characterization, diagnostic predictors, and predictive score development. Results from the PRO-BAC Cohort
Pedro María Martínez Pérez- Crespo, Álvaro Rojas, Joaquín Felipe Lanz- García, Pilar Retamar-Gentil, Jose María Reguera- Iglesias, Olalla Lima-Rodríguez, Alfonso Del Arco Jiménez, Jonathan Fernández-Suárez, Alfredo Jover-Sáenz, Josune Goikoetxea-Agirre, Eva León Jiménez, Mª Luisa Cantón, Pilar Ortega Lafont, Carlos Armiñanzas Castillo, Juan Sevilla Blanco, Jordi Cuquet Pedragosa, Lucía Boix- Palop, Berta Becerril Carral, Alberto Bahamonde, Teresa Marrodan Ciordia, Clara Natera Kindelán, Isabel María Reche Molina, Carmen Herrero Rodríguez, Inés Pérez Camacho, David Vinuesa, Fátima Galán-Sánchez, Alex Smithson, Esperanza Merino de Lucas, Antonio Sánchez Porto, Marcos Guzmán García, Inmaculada López- Hernández, Jesús Rodríguez Baño *, Luis Eduardo Lopez-Cortes. Antibiotics (Basel). 2022;11(6):707. doi: 10.3390/antibiotics11060707.
Staphylococcus aureus surface protein G (sasG) allelic variants: correlation between biofilm formation and their prevalence in methicillin-resistant S. aureus (MRSA) clones
Anna Carrera-Salinas, Aida González-Díaz, Daniel Antonio Vázquez-Sánchez, Mariana Camoez, Jordi Niubó, Jordi Càmara, Carmen Ardanuy, Sara Martí, M Ángeles Domínguez; REIPI/GEIH Study Groups Res Microbiol. 2022;173(3):103921. doi: 10.1016/j.resmic.2022.103921. Epub 2022 Jan 26.
Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project
Marco Mussa, Pedro María Martínez Pérez-Crespo, Luis Eduardo Lopez-Cortes, Pilar Retamar-Gentil, Adrián Sousa-Dominguez, Ane Josune Goikoetxea-Aguirre, José María Reguera-Iglesias, Eva León Jiménez, Isabel Fernández-Natal, Carlos Armiñanzas-Castillo, Lucía Boix-Palop, Jordi Cuquet-Pedragosa, Miguel Ángel Morán Rodríguez, Jonathan Fernandez-Suarez, Alfonso Del Arco-Jiménez, Alfredo Jóver-Saenz, Alberto Bahamonde-Carrasco, Fátima Galan-Sanchez, Juan Manuel Sánchez-Calvo, Alejandro Smithson-Amat, David Vinuesa-García, Antonio Sánchez-Porto, Inmaculada López-Hernández, Jesús Rodríguez-Baño; PROBAC REIPI/GEIH-SEIMC/SAEI group. Microbiol Spectr. 2022;10(4):e0005122. doi: 10.1128/spectrum.00051-22. Epub 2022 Jun 30.
Documento de consenso para el cribado de patología importada en inmunosuprimidos
Management of patients with suspected or confirmed antibiotic allergy. Executive summary of guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)
José Ramón Paño-Pardo 1, Esther Moreno Rodilla 2, Sara Cobo Sacristan 3, José Luis Cubero Saldaña 4, Leonor Periañez Párraga 5, José Luis Del Pozo León 6, Pilar Retamar Genti 7, Alejandro Rodríguez Oviedo 8, María José Torres Jaén 9, Pablo Vidal-Cortes 10, Carlos Colás Sanz 4. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Mar;41(3):181-186. doi: 10.1016/j.eimce.2022.08.010. Epub 2023 Jan 25.
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria
Vicente Pintado 1, Patricia Ruiz-Garbajosa 2, David Aguilera-Alonso 3, Fernando Baquero-Artigao 4, Germán Bou 5, Rafael Cantón 2, Santiago Grau 6, Belén Gutiérrez-Gutiérrez 7, Nieves Larrosa 8, Isabel Machuca 9, Luis Martínez Martínez 10, María Milagro Montero 11, Elena Morte-Romea 12, Antonio Oliver 13, José Ramón Paño-Pardo 12, Luisa Sorlí 11. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jun-Jul;41(6):360-370. doi: 0.1016/j.eimce.2022.06.014. Epub 2022 Dec 13. PMID: 36522272
